Stock Report

All about this stock under one free report Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Enlivex Therapeutics - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.10

up-down-arrow $-0.06 (-5.17%)

As on 04-Sep-2026 13:38EDT

Market cap

info icon

$24 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

0

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -165.80 -13.23 3.83 12.72 -11.77
Net Profit 56,474.29 24,115.71 8,329.17 249.35 154.37
EPS 28,223.98 11,009.91 3,549.54 176.99 122.67
Book Value -- -- 3,626.37 479.77 196.32
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info 1.11-12.89126.17-55.95-66.88
Return on Capital info 3.03-10.88126.09-54.36-62.64
Return on Assets info 0.92-11.35104.94-46.54-55.65
Debt to Equity (x) info ----0.000.020.03

Profitability

View Detailed Peer Comparison

ROCE

126.09

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
126.09
-54.36
-62.64
-40.67
-22.83
Peer Median
--
--
--
--
--
ROE

126.17

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
126.17
-55.95
-66.88
-43.78
-24.01
Peer Median
--
--
--
--
--
ROA

104.94

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
104.94
-46.54
-55.65
-38.16
-21.35
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
-1.00
Peer Median
--
--
--
--
--
EBIT Growth

0.09

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.09
48.32
-12.63
-33.75
-97.12
Peer Median
--
--
--
--
--
Net Profit Growth

8,329.17

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
8,329.17
48.35
6.41
-114.68
-22.36
Peer Median
--
--
--
--
--
EPS Growth

38.38

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
38.38
-5.58
0.07
-1.14
0.10
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.00

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.00
0.02
0.03
0.09
0.07
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.00
0.01
0.01
0.01
0.01
Peer Median
--
--
--
--
--
Current Ratio

193.24

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
193.24
6.84
5.57
7.92
18.32
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
5.61
7.74
20.91
Peer Median
--
--
--
--
--
Interest Coverage

-1,153.85

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
-1,153.85
-1,154.92
-2,075.29
-4.90
-58.80
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
-153.47
207.34
-2,591.54
-14,516.68
Peer Median
--
--
--
--
--
Payable days

2,540.80

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
2,540.80
548.88
606.93
664.22
448.54
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

0.00

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.00
-0.11
-1.73
-2.33
-7.91
Peer Median
--
--
--
--
--
Price / Book Value

0.00

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.00
0.07
1.67
1.27
1.35
Peer Median
--
--
--
--
--
EV/EBITDA

0.20

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Enlivex Therapeutics - ADR
0.20
1.47
-0.85
-1.08
-1.94
Peer Median
--
--
--
--
--
loading...
loading...